跳至主導覽
跳至搜尋
跳過主要內容
國立成功大學 首頁
English
中文
在 國立成功大學 搜尋內容
首頁
概要
研究單位
研究成果
專案
學生論文
設備
獎項
活動
查看斯高帕斯 (Scopus) 概要
林 博文
Doctor
外科部
電子郵件
linbw
mail.ncku.edu
tw
h-index
1035
引文
18
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2008
2026
每年研究成果
概覽
指紋
網路
專案
(2)
研究成果
(51)
類似的個人檔案
(6)
指紋
查看啟用 Bo-Wen Lin 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Colorectal Carcinoma
100%
Neoplasm
27%
Metastatic Carcinoma
26%
Gamma Urogastrone
21%
Epidermal Growth Factor Receptor 2
21%
Malignant Neoplasm
18%
Spindle Checkpoint
14%
Tumor Recurrence
14%
Next Generation Sequencing
13%
Upregulation
12%
Protein Expression
12%
Cancer
11%
Surgeon
10%
Metastasectomy
10%
Cell-Free DNA
10%
Autophagy
10%
Stricture
10%
Carcinogenicity
10%
Gracilis
10%
Mucinous Carcinoma
10%
Rectus Abdominis Muscle
10%
DNA Mismatch Repair
10%
Tumor Immunity
10%
Assessment of Humans
10%
Lung Infarction
10%
Balloon Dilatation
10%
Heterogeneous Nuclear Ribonucleoprotein
10%
Interleukin 16
10%
Propensity Score Matching
10%
Epidermal Growth Factor Receptor
10%
Nutrition Program
10%
Lymphocytic Infiltration
10%
Phosphoinositide 3-Kinase
10%
Enzyme Active Site
10%
Pyruvate Dehydrogenase Kinase
10%
Brain Metastasis
10%
Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase 4
10%
Epithelial Cell
10%
Clinical Significance
10%
Stoma
10%
Total Mesorectal Excision
10%
Synapsin II
10%
Mismatch Repair Protein
10%
Colon
10%
Rectal Prolapse
10%
Cancer Cell
9%
Recurrent Disease
9%
Cancer Therapy
8%
Diseases
8%
Cervical Cancer
7%
Biochemistry, Genetics and Molecular Biology
Epidermal Growth Factor Receptor
36%
Cancer Cell
36%
Genomics
28%
Oleic Acid
21%
DNA Analysis
21%
Next Generation Sequencing
21%
KRAS
18%
Gene Mutation
18%
Colon
17%
Carcinogenesis
14%
P53
14%
Angiopoietin
14%
NAD(P)H Oxidase
14%
Overall Survival
13%
Germline
12%
Germ Cell
12%
DNA Mismatch Repair
12%
Drug Resistance
12%
Ferroptosis
10%
CXCL9
10%
DNA Damage Response
10%
Somatic Mutation
10%
Capecitabine
10%
Pyruvate Dehydrogenase Kinase
10%
Bromodomain-Containing Protein 3
10%
Dual-Specificity Phosphatase
10%
CD151
10%
Circulating Tumor DNA
10%
Expression Quantitative Trait Loci
10%
FBXW7
10%
Mitochondrion
10%
Immune Response Gene
10%
Protein Expression
10%
Blood Level
10%
Interleukin 8
10%
Random Forest
9%
Mutated Genes
7%
Myc
7%
Phylogenetic Tree
6%
Pan-cancer
5%
In Vitro Study
5%
Tumor Volume
5%
Decision Tree
5%
Support Vector Machine
5%
Phosphatidylinositol 3-Kinase-Related Kinase
5%
Keyphrases
Aurora A
16%
Prognosis Analysis
10%
Pulmonary Metastasectomy
10%
Epidermal Growth Factor
10%
Aortoiliac
10%
HnRNP
10%
5-fluorouracil (5-FU)
10%
Cetuximab
10%
Metastatic Colorectal Cancer (mCRC)
10%
Mutational Landscape
10%
TRAM Flap
10%
Gracilis
10%
Stage III Colorectal Cancer
10%
Mucinous Adenocarcinoma
10%
Perineal Defect
10%
En Bloc Excision
10%
Locally Invasive
10%
Pelvic Defect
10%
Deficient Mismatch Repair (dMMR)
10%
Cell Cycle Regulation
10%
Tumorigenesis
10%
Human Epidermal Growth Factor Receptor 2 Amplification
10%
Mutation Impact
10%
Oxaliplatin-based Chemotherapy
10%
Adjuvant Capecitabine
10%
Cost Comparison
10%
Epidermal Growth Factor Receptor
10%
Immunomodulatory Therapeutics
10%
Pulmonary Infarction
10%
Cancer Stemness
10%
CD151
10%
MiR-137
10%
AURKC
10%
PDK3
10%
Tyro3
10%
Aurora-C
10%
Single Surgeon Experience
10%
Cell Cycle Genes
10%
Chemoradiation
10%
Transanal Total Mesorectal Excision (taTME)
10%
Neoadjuvant Chemoradiotherapy (nCRT)
10%
Colorectal mucinous Adenocarcinoma
10%
Defunctioning Stoma
10%
MYO18A
10%
Serous Adenocarcinoma
10%
Thiersch Procedure
10%
Dual Specificity Phosphatase 2
8%
Liver Metastasis
8%
Overall Response Rate
8%
FCER1G
7%
